Metabolome Changes in Cerebral Ischemia

Abstract

<jats:p>Cerebral ischemia is caused by perturbations in blood flow to the brain that trigger sequential and complex metabolic and cellular pathologies. This leads to brain tissue damage, including neuronal cell death and cerebral infarction, manifesting clinically as ischemic stroke, which is the cause of considerable morbidity and mortality worldwide. To analyze the underlying biological mechanisms and identify potential biomarkers of ischemic stroke, various in vitro and in vivo experimental models have been established investigating different molecular aspects, such as genes, microRNAs, and proteins. Yet, the metabolic and cellular pathologies of ischemic brain injury remain not fully elucidated, and the relationships among various pathological mechanisms are difficult to establish due to the heterogeneity and complexity of the disease. Metabolome-based techniques can provide clues about the cellular pathologic status of a condition as metabolic disturbances can represent an endpoint in biological phenomena. A number of investigations have analyzed metabolic changes in samples from cerebral ischemia patients and from various in vivo and in vitro models. We previously analyzed levels of amino acids and organic acids, as well as polyamine distribution in an in vivo rat model, and identified relationships between metabolic changes and cellular functions through bioinformatics tools. This review focuses on the metabolic and cellular changes in cerebral ischemia that offer a deeper understanding of the pathology underlying ischemic strokes and contribute to the development of new diagnostic and therapeutic approaches.</jats:p>

Decrease in membrane fluidity and traction force induced by silica-coated magnetic nanoparticles

“…For example, although transcriptomics can reflect enormous genotypic changes, it has been shown to be insufficient for understanding the actual phenotype [ 32 , 33 ]. In contrast, in the case of metabolomics, which can constitute an endpoint feature of biological phenotypes [ 34 , 35 ], no amplification methods are available for very low-abundance metabolites, and quantitative analysis of the targeted method might likely provide only a partial representation of the overall metabolism [ 36 ]. Accordingly, a combination of transcriptomics and metabolomics, termed "metabotranscriptomics", has been utilised for a more comprehensive analysis of cells and evaluation of nanotoxicity following treatment with nanoparticles [ 4 , 21 , 22 ].…”

miR-328-3p, a Predictor of Stroke, Aggravates the Cerebral Ischemia-Reperfusion Injury

“…Previous studies have shown that miRNAs are critical modulators of CI-concerned cellular biological processes, including proliferation, apoptosis and so on. 19 Serum miR-124 may serve as a molecular marker for acute ischemic stroke. 20 Through the JNK signaling pathway, miR-145 accelerates the proliferation of endothelial progenitor cells in CI rats.…”

Applications of Metabolomics in Forensic Toxicology and Forensic Medicine

“…One of the most leading causes of morbidity and mortality worldwide is cerebral ischemic disease, a common form of stroke. Cerebral ischemia is the fifth leading cause of death [ 75 ], and it is caused by the blockage of a blood vessel connected with a thrombus or embolus [ 76 ]. During brain ischemia, part of the brain lacks oxygen and nutrients, becoming damaged through induction of metabolic and cellular disturbances.…”